Concord Asset Management »

Regeneron Pharmaceuticals shares owned by Concord Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Concord Asset Management from 13F filings

Historical chart of Concord Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Concord Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Concord Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 1.1k 1051.24
2024-06-30 $959k 912 1051.03
2024-03-31 $504k 524 962.49
2023-12-31 $418k 476 878.29